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The effect of numbness on outcome from total knee
replacement
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ABSTRACT
INTRODUCTION Some patients report continuing pain and functional limitations after total knee replacement (TKR). While numb-
ness around the TKR scar is common, the impact of numbness is less clear. One particular activity that could be influenced by
numbness is kneeling. The aim of this study was to explore the impact of numbness around TKR scars on health related quality of
life and kneeling ability.
METHODS Fifty-six patients were recruited one year after primary TKR. Sensation around the knee was assessed through patient
self-reporting, monofilament testing and vibration, and patients’ distress was measured on a visual analogue scale. Patient reported
outcome measures (PROMs) including the Western Ontario and McMaster Universities (WOMAC®) index, the Knee injury and
Osteoarthritis Outcome Score (KOOS), the painDETECT® (Pfizer, Berlin, Germany) questionnaire and the EQ-5D™ (EuroQol, Rot-
terdam, Netherlands) questionnaire were used. Participants were also asked about kneeling ability.
RESULTS While 68% of patients reported numbness around their TKR scar, there was no statistically significant correlation
between numbness and distress at numbness (self-report: 0.23, p=0.08; monofilament: 0.15, p=0.27). Furthermore, numbness
did not correlate significantly with joint specific PROMs (WOMAC®: 0.21, p=0.13; KOOS: 0.18, p=0.19). However, difficulty with
kneeling did correlate with both self-reported numbness (0.36, p=0.020) and worse PROM scores (WOMAC® pain subscale: 0.62,
p<0.001; KOOS: 0.64, p<0.001).
CONCLUSIONS Numbness after knee replacement is common but is not associated with worse patient reported outcomes.
KEYWORDS
Numbness – Total knee replacement – Health related quality of life – Kneeling
Accepted 3 January 2017
CORRESPONDENCE TO
Julia Blackburn, E: jlrkblackburn@doctors.org.uk
In 2015 over 88,000 primary total knee replacement (TKR)
procedures were performed in England, Wales and Northern
Ireland.1 TKR is usually an effective surgical intervention for
providing relief from chronic knee pain and disability
although some patients report continuing pain and func-
tional limitations after surgery.2
Commonly assessed patient reported outcomes after TKR
include pain, function, general health and overall satisfac-
tion with the outcome of surgery. Despite between 71% and
100% of patients experiencing numbness around their TKR
scar,3–9 the consequences of this complication have received
little attention, perhaps in part because the area of numb-
ness typically regresses during the first two years following
surgery.4,6,7,9–11
Factors affecting the area and the duration of sensory loss
around the incision are not entirely clear. Some studies have
found that the size of the numb area is related to the length
of the scar6,7,11 or longer tourniquet time7 but others have
found no association.9 A more lateral incision has been asso-
ciated with reduced numbness3,7,12,13 while a study compar-
ing the medial parapatellar approach with a midline
approach showed no difference in the area of numbness.10
As a result, the evidence is lacking to develop guidance on
the prevention of postoperative numbness.
Although previous research has established that numb-
ness is a common occurrence after TKR, the impact of
numbness is less clear. Variability has been reported regard-
ing the extent to which patients notice the numbness and
are concerned about it.3,6 Only two studies have investigated
the association between numbness and patient reported out-
come measures (PROMs). One found numbness was not
associated with the Oxford knee score8 while the other
found it did correlate with the Western Ontario and McMas-
ter Universities (WOMAC®) osteoarthritis index as well as
the Knee injury and Osteoarthritis Outcome Score (KOOS).13
Consequently, although numbness around the TKR scar is
common, the effects of sensory loss on knee specific and
health related quality of life remain unclear.
One particular activity that could potentially be influenced
by numbness is kneeling. Kneeling following TKR can be dif-
ficult, with studies reporting 12–87% of patients finding it
extremely difficult or impossible to kneel.8,14–17 However,
kneeling can be important to patients. For example, a study
of Korean women found that 53.9% reported kneeling for
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religious reasons before their TKR.18 A review of the litera-
ture also revealed a number of studies correlating increased
knee osteoarthritis with occupations involving kneeling.19
Patients in some studies reported that they avoided kneel-
ing because of their own uncertainties or recommendations
from healthcare professionals.14,15,20 Although many
patients do not even attempt to kneel,20 in studies that
encouraged kneeling under supervision, many were able to
do so.14,20 Previous research has suggested that patients
with a smaller area of numbness and greater range of
motion find kneeling easier11,20 but study results are incon-
sistent.15 The aim of this study was therefore to explore the
impact of numbness around TKR scars on health related
quality of life and kneeling ability.
Methods
Ethical approval for the study was obtained from the local
National Health Service research ethics committee. All par-
ticipants provided informed written consent. Individuals
were eligible to participate if they had undergone a primary
TKR at least one year previously. Participants were recruited
by approaching consecutive patients who were attending a
follow-up appointment for another research study (APEX
[Arthroplasty Pain Experience] trial).21 Those with diabetic
neuropathy and those who had undergone revision surgery
were excluded. Computerised operation notes were exam-
ined for surgical details including surgical approach and
tourniquet time.
Assessment of numbness
Sensation around the knee was assessed in three ways: self-
reporting, monofilament testing (Bailey Instruments, Man-
chester, UK) and vibration testing (VibraTip™; McCallan
Medical, Nottingham, UK). For each method, the area of
numbness was recorded on cling film that was placed over
the knee. The cling film was then fixed to 160g/m2 card with
adhesive spray so the areas could be cut out and quantified
as a series of masses using an analytical balance with 0.1mg
resolution.
The order of testing was randomised by sequential selec-
tion of envelopes containing one of the six possible combi-
nations of tests. Details of the three assessment methods are
given below.
Self-report: Patients sat on an examination couch, with
their legs extended, and mapped the area of skin numbness
using their fingertips.
Monofilament: Numbness in the skin area surrounding
the scar was assessed at approximately 1cm intervals with a
monofilament. Before testing with a monofilament, patients
were asked to close their eyes. A 10g Semmes–Weinstein
monofilament was applied perpendicular to the skin and
pressure was applied until it buckled. This was repeated
three times and patients were asked to say ‘yes’ each time
they felt skin pressure from the monofilament.
Vibration: This was tested with the VibraTip™ device,
which contains a microvibrating motor driven by a button
cell that provides a specific vibration stimulus of reproduci-
ble amplitude with high face validity.22 Patients were asked
to close their eyes and say whether they felt a vibration on
‘touch 1’ or ‘touch 2’, when only one stimulus involved
vibration.
Distress caused by numbness
Patients were asked to rate their numbness and the dis-
tress this caused them on a 100mm visual analogue scale
(VAS).
Assessment of kneeling ability
Patients were asked to kneel on a thick silicone mat with
washable pigment so the area of contact could be meas-
ured and quantified. They were also asked about kneeling
and difficulties experienced when kneeling.
Health related quality of life
PROMs used to assess health related quality of life included
the WOMAC® index,23 the knee related quality of life sub-
scale from the KOOS questionnaire,24 the painDETECT®
(Pfizer, Berlin, Germany) questionnaire25 and the EQ-5D™
(EuroQol, Rotterdam, Netherlands) questionnaire.26
The WOMAC® index is a 24-item disease specific measure
that produces separate subscores for the severity of pain (0–
20), stiffness (0–20) and physical function (0–68). The KOOS
knee related quality of life subscale consists of four items
that assess the respondents’ confidence and awareness of
their knee. The painDETECT® questionnaire is a screening
tool for neuropathic pain. It comprises nine questions about
pain experienced over the previous four weeks, rated from 0
to 5. A total score of ≤12 indicates that the pain is unlikely to
have a neuropathic component and a score of ≥19 indicates
that the pain is likely to be neuropathic in origin. The EQ-
5D™ tool is a standardised health related quality of life ques-
tionnaire comprising five dimensions: mobility, self-care,
usual activities, pain or discomfort and anxiety or
depression.
Statistical analysis
In order to avoid problems with potentially non-parametric
data, Spearman’s correlation coefficient was used through-
out to compare PROMs, assessment of numbness, scar
length, tourniquet duration, difficulty in kneeling, reported
numbness and distress caused by numbness. A power calcu-
lation revealed that in order to enable valid analysis (with a
power of 80% and 5% statistical significance) of any correla-
tion between sensory loss and standardised assessments of
function and quality of life of 0.36 or more, 56 complete data-
sets were required.
Results
A total of 56 participants were recruited to the study. The
mean age of participants was 70 years (range: 53–87 years)
and 28 (50%) were female. All participants were assessed by
one clinician (JB) within three months of the one-year anni-
versary of their TKR.
Numbness data were available for all patients using the
self-report method and for 98% (55/56) using the monofila-
ment but for only 35% (20/56) using the VibraTip™ as many
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were unable to detect vibration anywhere on their knee. All
patients completed the health related quality of life PROMs.
Data regarding surgical details such as tourniquet duration
were complete for 75% of patients (42/56).
Numbness
On examination, 68% of patients (38/56) self-reported some
degree of numbness around their TKR scar while 56% (31/
55) had numbness when tested by monofilament. Only 36%
(20/56) were able to detect vibration anywhere around their
scar (although they were able to detect it on their hand as a
control).
Self-reported numbness correlated with monofilament
assessed numbness (0.45, p<0.0001) and VibraTip™
assessed numbness (0.51, p=0.021). The strongest correla-
tion was between monofilament numbness and VibraTip™
numbness (0.70, p=0.001).
In 23% of patients (13/56), no numbness was reported on
the day and 18% (10/56) reported having no numbness in
the previous four weeks. Fifty-six per cent of the patients
who had experienced numbness (26/46) reported no distress
as a result of their numbness. The median severity of numb-
ness and distress caused by the numbness, both measured
on a VAS, is shown in Table 1.
Correlations between measures of numbness in clinic
and VAS ratings are displayed in Table 2. All correlations
were statistically significant at the 5% level except those
between distress at numbness and clinical measures of
numbness.
Correlations between health related quality of life scores
and measures of numbness are shown in Table 3. The only
statistically significant correlations were between the pain-
DETECT® score and self-reported numbness (0.28,
p=0.037), and between the EQ-5D™ and numbness assessed
by VibraTip™ (0.55, p=0.012).
Scar length
The most common surgical approach was the medial para-
patellar (47/56), followed by the subvastus (6/56), midvas-
tus (2/56) and anteromedial approach (1/56). The mean
scar length was 172mm (range: 125–284mm), and there
was no statistically significant correlation between length
of scar and self-reported numbness (-0.03, p=0.82), monofi-
lament assessed numbness (-0.04, p=0.77) or VibraTip™
assessed numbness (0.17, p=0.50).
Tourniquet duration
The mean tourniquet duration was 75 minutes (range: 33–
133 minutes). There was no statistically significant correla-
tion between tourniquet duration and self-reported numb-
ness (0.23, p=0.14), monofilament assessed numbness
(0.15, p=0.35) or VibraTip™ assessed numbness (0.36,
p=0.18, n=16).
Kneeling
In the four weeks prior to completing the questionnaire,
63% of patients (35/56) had needed to kneel but 29% of
these (10/35) had rated this as impossible. Only 14% (8/56)
were able to kneel as easily as they would like. Difficulty
in kneeling correlated with self-reported numbness (-0.36,
p=0.020) and VibraTip™ assessed numbness (-0.62,
p=0.014, n=15) but did not correlate significantly with
monofilament assessed numbness (-0.07, p=0.68). Kneeling
ability correlated with all PROMs (Table 4).
Only 30% of patients (17/56) agreed to kneel during the
research appointment. Reasons given for not wanting to
attempt kneeling included pain, stiffness, having both
knees affected, reduced range of movement and
numbness.
Discussion
While 68% of patients in our study reported numbness
around their TKR scar, no significant correlation was found
between numbness and distress at numbness. Furthermore,
numbness was not significantly correlated with joint specific
PROMs. However, difficulty in kneeling did correlate with
both self-reported numbness and worse PROM scores.
Our study has a number of strengths. Both objective
monofilament assessed numbness and self-reported numb-
ness was analysed as well as the effect on health related
quality of life. Our study adds to the current literature
as the two previous studies on numbness around TKR
scars investigated either self-reported numbness8 or
Table 1 Severity of self-reported numbness measured on a
100mm VAS
Median VAS score
Numbness that day 20 (range: 0–95)
Numbness over the previous 4 weeks 19.5 (range: 0–97)
Distress at numbness 1 (range: 0–78)
VAS = visual analogue scale
Table 2 Spearman’s rank correlation coefficients for correlation between area of numbness and severity/distress at numbness
Self-report (n=56) Monofilament (n=55) VibraTip™ (n=20)
Severity of numbness that day 0.67 (p<0.0001) 0.50 (p<0.0001) 0.53 (p=0.017)
Severity of numbness over previous 4 weeks 0.62 (p<0.001) 0.49 (p<0.0001) 0.53 (p=0.017)
Distress at numbness 0.23 (p=0.08) 0.15 (p=0.27) 0.13 (p=0.58)
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monofilament assessed numbness13 but no study has
included both assessment methods.
The proportion of patients in our study with self-
reported numbness around their TKR scar (68%) is similar
to that in other studies,3–9 and distress at numbness varies
between 8%3 and 20%6 in the literature. However, there
have been no other studies that have calculated a correla-
tion between numbness and distress.
In our study, numbness did not correlate significantly
with joint specific PROMs (including the WOMAC® score
and KOOS) or health related quality of life (as measured by
the EQ-5D™). A study of 49 TKRs also found no correlation
with Oxford knee score or patient satisfaction.8 Although a
study comparing midline with anterolateral skin incisions
found that a smaller area of monofilament assessed numb-
ness did correlate with better WOMAC® scores and KOOS
results at one year, their correlations were weak with wide
confidence intervals (WOMAC®: r2=-0.104, 95% confidence
interval [CI]: -0.309–-0.001; KOOS: r2=-0.166, 95% CI: -
0.426–-0.007).13
Our study found that although self-reported numbness
did correlate weakly with the painDETECT® score, monofi-
lament assessed numbness did not. The differences
between the two assessment methods may be due to psy-
chological factors; one study observed that patients were
more than three times more likely to report numbness if it
was discussed during the consent process.27
For our patients, difficulty in kneeling correlated moder-
ately with worse PROM scores. A study of 206 TKRs also
found a significant moderate correlation between kneeling
ability and WOMAC® score at 1 and 2 years28 but other stud-
ies found no correlation.8,15 This may be because patients
have adapted to perform various activities without kneeling
prior to their surgery so difficulty in kneeling postoperatively
does not impact on their PROM scores.
The results of our study showed a weak correlation
between difficulty in kneeling and greater self-reported
numbness but not monofilament assessed numbness. Of the
other studies considering kneeling ability, only one assessed
numbness around the TKR scar but it did not correlate
numbness and kneeling ability.8 However, supervision of
kneeling by clinicians has been shown to improve patients’
confidence in their kneeling ability20 so any association with
self-reported numbness could diminish.
It is a limitation of our study that we did not control for
confounding factors. For example, range of movement may
have contributed to associations between difficulty in
kneeling and worse PROM scores. Other studies have
shown correlations between difficulty in kneeling and a
reduced range of movement.16,20,28
Despite this, our findings that numbness around TKR
scars does not significantly correlate with distress or joint
specific PROM scores and health related quality of life
should allow clinicians to reassure patients about the impact
of any numbness they may experience. Difficulty in kneeling
following TKR is a complex problem and further research is
needed into associations with numbness, PROMs and range
of movement. Comparing kneeling ability prior to TKR with
postoperative ability may provide information about how dif-
ficulty in kneeling affects PROMs. The effect of interventions
to improve confidence in kneeling ability on PROMs could
also be explored.
Conclusions
This study found no statistically significant association
between numbness around TKR scars and joint specific
PROMs. However, there was an association between self-
reported numbness and difficulty in kneeling. Patients who
could not kneel reported worse PROM scores. Although
larger studies might identify factors that contribute to
impaired kneeling and PROMs more clearly, our study sug-
gests that numbness after knee replacement is not associ-
ated with worse patient reported outcomes.
Table 3 Spearman’s rank correlation coefficients for correlation between measures of knee function pain and health related
quality life and measures of numbness
WOMAC® pain WOMAC® stiffness WOMAC® function KOOS painDETECT® EQ-5D™
Self-report (n=56) 0.21 (p=0.13) 0.10 (p=0.48) 0.20 (p=0.14) 0.18 (p=0.19) 0.28 (p=0.037) -0.17 (p=0.22)
Monofilament (n=55) -0.01 (p=0.97) 0.02 (p=0.88) -0.09 (p=0.52) -0.08 (p=0.55) -0.07 (p=0.96) 0.20 (p=0.14)
VibraTip™ (n=20) -0.33 (p=0.16) -0.13 (p=0.60) -0.35 (p=0.14) -0.31 (p=0.18) -0.13 (p=0.57) 0.55 (p=0.012)
Table 4 Spearman’s rank correlation coefficients for
correlation between patient reported outcome measures
(PROMs) and kneeling ability
PROMs Correlation
WOMAC® pain 0.62 (p<0.001)
WOMAC® stiffness 0.48 (p=0.002)
WOMAC® function 0.59 (p<0.001)
KOOS 0.64 (p<0.001)
painDETECT® 0.55 (p<0.001)
EQ-5D™ -0.73* (p<0.001)
*A higher score for EQ-5D™ indicates a better quality of life while
a higher score for the other PROMs indicates a worse quality of
life.
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